Cost Comparison Among First Line Monoclonal Antibodies-Based Oncology Treatment Protocols
Value Health
.
2014 Nov;17(7):A629.
doi: 10.1016/j.jval.2014.08.2247.
Epub 2014 Oct 26.
Authors
M Jakovljevic
1
,
F S Gutzwiller
2
,
M Schwenkglenks
2
,
O Milovanovic
3
,
N Rancic
4
,
M Varjacic
3
,
D Stojadinovic
5
,
A Dagovic
6
,
K Matter-Walstra
2
Affiliations
1
The Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia and Montenegro.
2
University of Basel, Basel, Switzerland.
3
Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia and Montenegro.
4
Military Medical Academy University of Defence Belgrade, Belgrade, Serbia and Montenegro.
5
Urology Clinic, University Clinical Center Kragujevac, Kragujevac, Serbia and Montenegro.
6
Oncology and Radiation Therapy Center, Clinical Center Kragujevac, Kragujevac, Serbia and Montenegro.
PMID:
27202230
DOI:
10.1016/j.jval.2014.08.2247
No abstract available